NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · PPLPHARMA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Piramal Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 0.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Piramal Pharma Limited’s forward annual dividend is ₹0.11 per share, paid annual. The forward yield is 0.05% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Piramal Pharma Limited’s next earnings report is currently expected on Feb 2, 2027, with estimated earnings per share of ₹0.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Piramal Pharma Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:50 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2026 | Jul 28, 2025 | -₹0.62+9.49% vs estimate | ₹19.34B-3.36% vs estimate |
|---|
| Q4 2025 | May 14, 2025 | ₹1.20+3.45% vs estimate | ₹27.55B-3.56% vs estimate |
|---|
| Q3 2025 | Jan 28, 2025 | ₹0.03-97.6% vs estimate | ₹22.04B+3.69% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹1,352.00+₹7.00 (+0.52%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.45% below the high.
₹1,378.90+₹20.90 (+1.54%)
Cipla Limited’s quoted price sits in the lower half of its reported 52-week range, 13.46% below the high.
₹2,492.80+₹23.50 (+0.95%)
Mankind Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 5.65% below the high.
₹2,011.00+₹21.10 (+1.06%)
Lupin Limited’s quoted price sits in the lower half of its reported 52-week range, 20.5% below the high.
₹3,090.00+₹15.50 (+0.5%)
Gland Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.55% below the high.
₹3,462.00+₹2.30 (+0.07%)
Ajanta Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 8.8% below the high.
